Table 2 Sodiodemographic and clinical characteristics of the sample of 100 OCD patients

From: Do polygenic risk and stressful life events predict pharmacological treatment response in obsessive compulsive disorder? A gene–environment interaction approach

Age, Years, Mean ± SD (Range)

33.42 ± 9.67 (18–57)

   

Male/Female, n (%)

56/44 (56.0%, 44.0%)

   

Age at Onset of OCD, Mean ± SD (Range)

21.62 ± 10.03 (6–70)

   

Baseline Y-BOCS Score, Mean±SD (Range)

Global

26.26 ± 5.16 (11–36)

   

Obsessions

13.12 ± 3.24 (0-26)

   

Compulsions

12.98 ± 2.99 (0- 19)

   

Baseline HDRS, Score, Mean±SD (Range)

12.7 ± 5.05 (2–28)

   

Current Comorbid Diagnosis, n (%)

No comorbid disorder

53 (53.0)

   

Other Anxiety Disorder

10 (10.0)

   

Mood Disorder

9 (9.0)

   

Tics

3 (3.0)

   

Eating Disorders

2 (2.0)

   

Other

23 (23.0)

   

Presence of Dimensions in worst-ever period n (%)

Aggresive/checking

70 (70.0)

   

Symmetry/Ordering

43 (43.0)

   

Contamination/cleaning

49 (49.0)

   

Hoarding

26 (26.0)

   

Miscelaneos

32 (32.0)

   

History of Pharmacological Resistance n (%)

1 SSRI

27 (27.0)

   

2 SSRIs

12 (12.0)

   

>2 SSRIs

61 (61.0)

   

Family Psychiatric History n (% of patients)

1st grade

2nd grade

3rd grade

Total

No psychiatric diagnosis

47 (47.0)

38 (38.0)

80 (80.0)

30 (30.0)

OCD

2 (2.0)

11 (1.0)

1 (1.0)

10 (10.0)

Subclinic OCD

6 (6.0)

5 (5.0)

1 (1.0)

12 (12.0)

Anxiety disorder different from OCD

13 (13.0)

4 (4.0)

0 (0.0)

15 (15.0)

Mood disorder

14 (14.0)

28 (28.0)

1 (1.0)

28 (28.0)

Psychotic disorder

5 (5.0)

5 (5.0)

8 (8.0)

13 (13.0)

Drug abuse

8 (8.0)

2 (2.0)

3 (3.0)

10 (10.0)

Eating disorder

1 (1.0)

0 (0.0)

0 (0.0)

1 (1.0)

Tics/ Guilles de la Tourette

2 (2.0)

5 (5.0)

4 (4.0)

9 (9.0)

Others

2 (2.0)

2 (2.0)

2 (2.0)

5 (5.0)

  1. OCD obsessive-compulsive disorder, Y-BOCS Yale–Brown obsessive-compulsive scale, HDRS, Hamilton depression rating scale